Radical prostatectomy versus radiation and androgen deprivation therapy for clinically localized prostate cancer: How good is the evidence?

International Journal of Radiation Oncology Biology Physics

Volumn 93, Issue 5, 2015, Pages 1064-1070

  Roach, Mack ^a   Ceron Lizarraga, Tania L ^a   Lazar, Ann A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; GRADING; QUALITY CONTROL; UROLOGY;

ANDROGEN DEPRIVATION THERAPY; CAUSE-SPECIFIC SURVIVAL; CLINICAL CHARACTERISTICS; CURRENT TREATMENTS; LOCALIZED PROSTATE CANCER; OBSERVATIONAL STUDY; RADICAL PROSTATECTOMY; RANDOMIZED CONTROLLED CLINICAL TRIALS;

RADIOTHERAPY;

ANDROGEN; ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CAUSE SPECIFIC SURVIVAL; CHARLSON COMORBIDITY INDEX; COMORBIDITY; HUMAN; INTERMETHOD COMPARISON; MALE; META ANALYSIS; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; SYSTEMATIC REVIEW; AGE; AGED; BLOOD; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; REPRODUCIBILITY; STANDARDS; SURVIVAL;

AGE FACTORS; AGED; ANDROGEN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 84946761409     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.08.005     Document Type: Review

References (36)

1. M. Roach 3rd, and K. Thomas Overview of randomized controlled treatment trials for clinically localized prostate cancer: Implications for active surveillance and the United States preventative task force report on screening? J Natl Cancer Inst Monogr 2012 2012 221 229
2. P. Grimm, I. Billiet, D. Bostwick, and et al. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group BJU Int 109 Suppl 1 2012 22 29
3. B.H. Lee, A.S. Kibel, J.P. Ciezki, and et al. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence Eur Urol 67 2015 204 209
4. P. Sooriakumaran, T. Nyberg, O. Akre, and et al. Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: Observational study of mortality outcomes BMJ 348 2014 g1502
5. F. Petrelli, I. Vavassori, A. Coinu, and et al. Radical prostatectomy or radiotherapy in high-risk prostate cancer: A systematic review and metaanalysis Clin Genitourin Cancer 12 2014 215 224
6. J.L. Mohler, A.J. Armstrong, R.R. Bahnson, and et al. Prostate cancer, version 3.2012: Featured updates to the NCCN guidelines J Natl Compr Canc Netw 10 2012 1081 1087
7. J.M. Degroot, M.D. Brundage, M. Lam, and et al. Prostate cancer-specific survival differences in patients treated by radical prostatectomy versus curative radiotherapy Can Urol Assoc J 7 2013 E299 E305
8. M.R. Cooperberg, A.J. Vickers, J.M. Broering, and et al. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer Cancer 116 2010 5226 5234
9. D. Atkins, M. Eccles, S. Flottorp, and et al. Systems for grading the quality of evidence and the strength of recommendations I: Critical appraisal of existing approaches. The GRADE Working Group BMC Health Serv Res 4 2004 38
10. L. Phi, R. Ajaj, M.H. Ramchandani, and et al. Expanding the grading of recommendations assessment, development, and evaluation (Ex-GRADE) for evidence-based clinical recommendations: Validation study Open Dent J 6 2012 31 40
11. G.H. Guyatt, A.D. Oxman, and H.J. Schunemann GRADE guidelines: An introduction to the 10th-13th articles in the series J Clin Epidemiol 66 2013 121 123
12. M. Roach 3rd, and M. Alexander The prognostic significance of race and survival from breast cancer: A model for assessing the reliability of reported survival differences J Natl Med Assoc 87 1995 214 219
13. P.B. Bach, D. Schrag, O.W. Brawley, and et al. Survival of blacks and whites after a cancer diagnosis JAMA 287 2002 2106 2113
14. E. Rivin del Campo, K. Thomas, V. Weinberg, and et al. Erectile dysfunction after radiotherapy for prostate cancer: A model assessing the conflicting literature on dose-volume effects Int J Impot Res 25 2013 161 165
15. S.H. Giordano, Y.F. Kuo, Z. Duan, and et al. Limits of observational data in determining outcomes from cancer therapy Cancer 112 2008 2456 2466
16. A. Bill-Axelson, L. Holmberg, H. Garmo, and et al. Radical prostatectomy or watchful waiting in early prostate cancer N Engl J Med 370 2014 932 942
17. N.M. Laird, and J.H. Ware Random-effects models for longitudinal data Biometrics 38 1982 963 974
18. K. Akakura, H. Suzuki, T. Ichikawa, and et al. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: Results at median follow-up of 102 months Jpn J Clin Oncol 36 2006 789 793
19. J.D. Tward, C.M. Lee, L.M. Pappas, and et al. Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: Impact of age at diagnosis Cancer 107 2006 2392 2400
20. A. Tewari, G. Divine, P. Chang, and et al. Long-term survival in men with high grade prostate cancer: A comparison between conservative treatment, radiation therapy and radical prostatectomy: A propensity scoring approach J Urol 177 2007 911 915
21. A. Merglen, F. Schmidlin, G. Fioretta, and et al. Short- and long-term mortality with localized prostate cancer Arch Intern Med 167 2007 1944 1950
22. L. Liu, A.L. Coker, X.L. Du, and et al. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer J Surg Oncol 97 2008 583 591
23. S.A. Boorjian, R.J. Karnes, R. Viterbo, and et al. Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer Cancer 117 2011 2883 2891
24. A.S. Kibel, J.P. Ciezki, E.A. Klein, and et al. Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era J Urol 187 2012 1259 1265
25. R.M. Hoffman, T. Koyama, K.H. Fan, and et al. Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer J Natl Cancer Inst 105 2013 711 718
26. K.G. Nepple, A.J. Stephenson, D. Kallogjeri, and et al. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity Eur Urol 64 2013 372 378
27. S. Yamamoto, S. Kawakami, J. Yonese, and et al. Long-term oncological outcome in men with T3 prostate cancer: Radical prostatectomy versus external-beam radiation therapy at a single institution Int J Clin Oncol 19 2014 1085 1091
28. M. Sun, J.D. Sammon, A. Becker, and et al. Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: A comparative effectiveness evaluation BJU Int 113 2014 200 208
29. C.K. Tsao, K.P. Gray, M. Nakabayashi, and et al. Patients with biopsy Gleason 9 and 10 prostate cancer have significantly worse outcomes compared to patients with Gleason 8 disease J Urol 194 2015 91 97
30. F. Abdollah, J. Schmitges, M. Sun, and et al. Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population-based analysis Int J Urol 19 2012 836 844
31. M. Roach 3rd Radical prostatectomy v radiation: Only a randomised trial can provide the answer BMJ 348 2014 g2266
32. J.B. Eifler, E.B. Humphreys, M. Agro, and et al. Causes of death after radical prostatectomy at a large tertiary center J Urol 188 2012 798 801
33. J. Hansen, G. Gandaglia, M. Bianchi, and et al. Re-assessment of 30-, 60- and 90-day mortality rates in non-metastatic prostate cancer patients treated either with radical prostatectomy or radiation therapy Can Urol Assoc J 8 2014 E75 E80
34. M.M. Kim, K.E. Hoffman, L.B. Levy, and et al. Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease? Eur J Cancer 48 2012 1664 1671
35. A. Kalbasi, J. Li, A. Berman, and et al. Dose-escalated irradiation and overall survival in men with nonmetastatic prostate cancer JAMA Oncol 2015 Jul 16 [Epub ahead of print]
36. G. Arcangeli, L. Strigari, S. Arcangeli, and et al. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer Int J Radiat Oncol Biol Phys 75 2009 975 982